Treatment Registry
TR-0973 ActiveRecorded October 2026

Compounded tirzepatide

Sold by Remote Pharmacy · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Compounded tirzepatide injection starting rate

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$229.99/mo”

$229.99Published figureCharged todayNot verified
Price sources
Visit Remote Pharmacy

We earn nothing from this link. It opens Remote Pharmacy's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberBoth
CancellationCancel before the doctor consultation for a full refund. After consultation but before shipment, the refund excludes a $30 consultation fee. Shipped medication is non-refundable. Subscription cancellation stops future payments and shipments.
MembershipNot disclosed
Consult fee$0, included in program price. Prescription, doctor consultation and ongoing support are included in the advertised treatment price.

Recorded from remotepharmacy.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — This is Remote Pharmacy’s weekly subcutaneous tirzepatide injection, separate from its sublingual tablets. The product page describes drawing up a prescribed dose but does not name the dispensing container. Consultation takes place by chat or video depending on location. The quoted starting rate includes clinical support; higher doses may cost more.

3 further notes concern other Remote Pharmacy programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0973
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Remote Pharmacy — compounded tirzepatide (TR-0973). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0973

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.